Skip to content

Ironsuppletion trial

Optimizing Iron suppletion trial after Roux- en -Y Gastric Bypass

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2014-002322-12-NL
Enrollment
Unknown
Registered
2014-06-16
Start date
2014-07-24
Completion date
Unknown
Last updated
2014-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who underwent a gastric bypass and develop an irondeficiency postoperatively. The medical condition which is investigated is irondeficiency

Interventions

Sponsors

Rijnstate Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients who underwent a gastric bypass and developped an irondeficiency postoperatively (ferritin=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: iron deficiency preoperatve, bloodtransfusions during study period, ironcontaining nutritional supplements except the 'standard' multivitamins after bariatric surgery, decreased renal failure, excessive manstruational blood loss, anemia not caused by iron deficiency, accumulation of iron, hypersensitivity for one of the medicinal products, psychiatric illness, pregnancy. Acute and chronic infection or other inflammationreactions, liver dysfunction.

Design outcomes

Primary

MeasureTime frame
Main Objective: evaluation on teh optimal treatment for an irondificiency after a roux- en -y gastric bypass;Secondary Objective: What is the effective time of Ferinject? Evaluate the patients preference for either oral treatment or intravenous treatment;Primary end point(s): normal value serum ferritin;Timepoint(s) of evaluation of this end point: 6,12,26 and 53 weeks after starting therapy

Secondary

MeasureTime frame
Secondary end point(s): enquetes with the preferece for oral or intravenous ironsuppletion;Timepoint(s) of evaluation of this end point: 6,12,26 and 53 weeks after starting therapy

Countries

Netherlands

Contacts

Public ContactWendy Schijns

Rijnstate

wschijns@rijnstate.nl

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026